amylin analog vs glp 1 Forget GLP-1: Wants to Be the Next Big Thing CagriSema: New GLP-1 & Amylin

A powerhouse for both fat loss and metabolic health

A recent national cohort study examined data from more than 150,000 adults on dialysis who had type 2 diabetes and found GLP-1 receptor agonist use was linked to a 23% lower risk for mortality and 66% greater likelihood of kidney transplant wait-listing

In Johnson & Johnsons July earnings call, top officials said McNeils over-the-counter revenue had surged by 26 percent

Cytidine-5'-diphosphocholine (Citicoline): a pilot study in patients with non-arteritic ischaemic optic neuropathy

Understanding whether these symptoms result from direct drug effects, rapid weight loss, or other factors is essential for patients and clinicians

Because tirzepatide activates two receptors rather than one, the biological response to reduced exposure may not mirror semaglutide directly